Page 345 - Tata Chemical Annual Report_2022-2023
P. 345

Integrated Annual Report 2022-23  01-83  84-192              193-365
               Integrated Report      Statutory Reports       Financial Statements
                                                              Consolidated


 (E)  The defined benefit scheme is administered by a fund that is legally separated from the Group. Responsibility for governance of   4.   Other information
 the scheme lies with the board of trustees. The board of trustees must be composed of representatives of the Group and scheme   ` in crore
 participants in accordance with the scheme rules and on timely basis, the board of trustees reviews the level of funding for the   Particulars   Addition to non-current assets*  Depreciation and amortisation  Other non-cash expenses**
 scheme as required by legislation. Such a review includes the asset-liabilities matching strategy and investment risk management   Year ended    Year ended    Year ended    Year ended    Year ended     Year ended
 policy and is used to determine the schedule of contributions payable by and agreed with the Group.  March 31, 2023  March 31, 2022 March 31, 2023  March 31, 2022 March 31, 2023  March 31, 2022
             (i)   Basic chemistry products   1,475     1,619        752          683         116          149
 41.  Segment information  (ii)   Specialty products   260   183     125          109          50           24
 41.1 Continuing operations                1,735       1,802         877          792         166          173
 (a)  Information about operating segments   Unallocated   5    24    15           14          25           10
      The Company has 2 reportable segments which are the Company's strategic business units. These business units offer different   1,740   1,826   892   806   191   183
 products and are managed separately. Reportable Segments approved by Board of Directors are as under:  *Comprises additions to Property, plant and equipment, Capital work-in-progress, Goodwill, Right-of-use assets, Other intangible assets and Intangible
            assets under development.
     -   Basic chemistry products - Soda Ash, Salt and other bulk chemicals
            **Comprises of Provision for employee benefits expense, Provision for doubtful debts and advances/bad debts written off, Provision for contingencies,
    -   Specialty products - Nutrition solutions, agri Solutions, advance materials, etc.  Foreign exchange gain/(loss) and (Profit)/ loss on assets sold or discarded.
 ` in crore
 Year ended    Year ended    (b)  Information about geographical areas
 Particulars
 March 31, 2023  March 31, 2022     The geographical segments revenue are disclosed on the basis of sales as follows:
 1. Segment revenue (Revenue from operations)      - Asia (other than India): Comprising sales to customers located in Asia (other than India).
 (i)  Basic chemistry products   13,597   9,758      - Europe: Comprising sales to customers located in Europe.
 (ii)  Specialty products   3,198   2,826      - Africa: Comprising sales to customers located in Africa.
 16,795   12,584
 Inter segment revenue   (28)  (12)     - America: Comprising sales to customers located in America.
 16,767   12,572
 Unallocated    22    50   1.    Geographical Segment revenue*
 16,789   12,622   Year ended March 31, 2023                                                           ` in crore
 2. Segment result (Reconciliation with profit from continuing operations)   Particulars   Basic chemistry products  Specialty products  Unallocated  Total
 (i)  Basic chemistry products (note 34)   3,028   1,486   (i)  India   4,889   2,305          22         7,216
 (ii)  Specialty products    91   168
 Total Segment results   3,119   1,654   (ii)  Asia (other than India)   577    325             -          902
 Net unallocated income/(expenditure)    29    90   (iii)  Europe   2,496       111             -         2,607
 Finance costs    (406)   (303)  (iv)  Africa                 451                 44            -          495
 Profit before share of profit/loss from investment in joint ventures and   2,742   1,441   (v)  America   5,137   397   -  5,534
 associate and tax   (vi)  Others                              19                 16            -           35
 Share of Profit/(loss) of joint ventures and associate (net of tax)    (2)  226   13,569   3,198    22    16,789
 Tax expense    (288)   (267)
 Profit for the year from continuing operations   2,452   1,400
             Year ended March 31, 2022                                                                 ` in crore
 3.   Segment assets and segment liabilities*  Particulars  Basic chemistry products    Specialty products    Unallocated    Total
 ` in crore  (i)   India                                     3,681             2,196           50         5,927
  Segment assets    Segment liabilities   (ii)   Asia (other than India)   249   153            -          402
 Particulars    As at     As at    As at     As at   (iii)  Europe   1,844        54            -         1,898
 March 31, 2023   March 31, 2022   March 31, 2023   March 31, 2022   (iv)  Africa   277    44   -          321
 (i)  Basic chemistry products   22,177   19,475    4,494    4,018   (v)   America   3,682   375   -      4,057
 (ii)  Specialty products    3,112    3,216   959    1,084   (vi)  Others    13   4             -           17
 25,289   22,691    5,453    5,102                           9,746            2,826            50        12,622
 Unallocated    9,795   11,152    8,989    9,584   * Including operating revenues and net off inter segment revenue
 35,084   33,843   14,442   14,686
 * Including assets held for sale





 342                                                                                                       343
   340   341   342   343   344   345   346   347   348   349   350